マラリア治療の世界市場

マラリア治療の世界市場は2030年までに224億米ドルに到達

2024年に53億米ドルと推定されるマラリア治療の世界市場は、2024～2030年の分析期間においてCAGR 27.2%で成長し、2030年には224億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるジェネリック医薬品治療は、CAGR26.3%を記録し、分析期間終了時には123億米ドルに達すると予測されます。オリジネーター治療セグメントの成長率は、分析期間中CAGR 29.5％と推定されます。

米国市場は14億米ドルと推定、中国はCAGR 35.6％で成長すると予測

米国のマラリア治療市場は、2024年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに55億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは35.6％となります。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ22.1%と24.4%と予測されています。欧州では、ドイツがCAGR約22.9%で成長すると予測されています。

世界のマラリア治療市場- 主要動向と促進要因のまとめ

マラリア治療が流行地域全体で公衆衛生の優先事項であり続ける理由とは？

マラリア治療は、特に熱帯・亜熱帯地域で毎年数十万人の死亡者を出しており、5歳未満の子供が最も弱い立場にあるなど、その影響が広範囲に及んでいるため、世界の公衆衛生活動の主要な焦点であり続けています。マラリアは、予防と啓発の面で大きな進歩を遂げたにもかかわらず、アフリカ、東南アジア、ラテンアメリカの一部、オセアニアの保健制度に課題をもたらし続けています。アノフェレス蚊によって媒介され、マラリア原虫によって引き起こされるこの病気は複雑であるため、対象種や地域の薬剤耐性パターンによって異なる、的を絞った治療プロトコルが必要となります。ほとんどの場合、マラリア原虫は急速に増殖し、迅速に治療しなければ重篤な合併症を引き起こす可能性があるため、最もリスクが高いです。迅速な診断と効果的な薬剤投与は、この病気の負担を軽減し、蔓延を防ぐために非常に重要です。貧困、労働生産性の低下、高い罹患率と死亡率との関連から、国内外の保健機関は、その戦略においてマラリア治療を優先しています。世界保健機関（WHO）は、合併症を伴わないマラリア治療のゴールドスタンダードとなっているアルテミシニンベースの混合療法（ACTs）を展開する国々を支援し続けています。しかし、アジアやアフリカの一部で薬剤耐性が出現していることから、継続的な監視と調査の必要性が浮き彫りになっています。診断法、薬剤、地域保健介入へのアクセスを向上させる努力は、マラリア治療を単なる医学的問題ではなく、感染地域の経済成長と生活の質に影響を与える発展的な問題にしています。

医薬品開発と診断の進歩はマラリア管理をどのように強化しているか？

製薬研究と診断における技術革新は、マラリアの診断、治療、管理方法を変革し、マラリアの制圧と最終的な撲滅を目指す取り組みに新たな希望をもたらしています。アルテミシニンをベースとする併用療法は依然として最前線の治療法であるが、耐性化の懸念が高まる中、新しい製剤や第2世代の抗マラリア化合物の開発が進められています。研究者は、特に農村部や資源が限られた環境において、治療プロトコルを簡素化し、アドヒアランスを向上させる単回投与治療薬、合剤治療薬、長時間作用型治療薬の開発に注力しています。一方、迅速診断検査（RDT）のようなポイントオブケア診断は、早期発見を大幅に改善し、高度な検査インフラを必要とせずに、ヘルスケアワーカーが異なる原虫種を区別できるようになりました。これらのツールは、適切な治療を決定し、耐性を加速させる抗マラリア薬の誤用を避けるために不可欠です。さらに、ゲノム研究の開発により、寄生虫耐性の進化が解明され、長期にわたって効果を維持する標的療法の開発に役立っています。注射用抗マラリア薬や新しい点滴製剤は、重症例に導入されつつあり、緊急時の患者の安定化を早め、死亡率を減少させることができます。新規のエンドペルオキシド化合物や伝達阻害剤など、いくつかのパイプライン医薬品が臨床試験中であり、治療手段の拡大を目指しています。デジタルヘルスツールやモバイルプラットフォームは、アウトブレイクの追跡、治療効果のモニタリング、手の届きにくいコミュニティでの確実な投薬に利用されています。こうした進歩は、患者の転帰を向上させるだけでなく、より正確なデータと介入ツールを提供することで、公衆衛生システムの強化にもつながっています。

マラリア治療戦略に影響を与える世界の保健・社会経済動向とは？

世界の保健衛生の優先順位と社会経済的ダイナミクスは、マラリア治療戦略を形成し、保健システムがいかに効果的にアウトブレイクに対応できるかを決定する上で極めて重要な役割を果たしています。気候変動、都市化、土地利用の変化は蚊の生息地に影響を及ぼし、マラリアの感染パターンを変化させ、以前は感染していなかった地域にも感染範囲を広げています。移民や難民の移動もマラリアの蔓延に寄与しており、しばしば受け入れ地域の保健インフラに負担をかけています。経済的不平等により、社会から疎外された人々のタイムリーな診断と治療へのアクセスが制限され続けており、マラリアは貧困の原因であると同時に結果でもあります。保健省および国際的なドナーは、特に疾病の負担が最も大きい農村部において、より広範な一次医療サービスにマラリア治療を統合することにますます重点を置くようになっています。官民パートナーシップを含む協力的な取り組みにより、効果的な治療を持続的に利用するために不可欠な、医薬品調達、現地製造、サプライチェーンの信頼性の向上が可能になりつつあります。地域保健ワーカーや草の根の保健プログラムは、第一選択の治療を実施し、診断検査を行うための訓練を受けており、国のマラリア・プログラムの範囲を拡大しています。特に親や介護者を対象とした教育キャンペーンでは、再発や耐性を避けるために治療レジメンを完了することの重要性が強調されています。政策レベルでは、各国政府は世界基金やWHOのような組織と協力して、地域特有の治療プロトコルを実施し、調査イニシアチブを支援し、国際協力を促進しています。このような社会経済的、地政学的な考察は、マラリア治療の複雑さを浮き彫りにし、医薬品にとどまらず、インフラ、教育、公平性に焦点を当てた政策など、多面的な戦略の必要性を強調しています。

世界のマラリア治療市場の成長を促進する要因とは？

世界のマラリア治療市場の成長は、疫学的緊急性、科学的イノベーション、国際的資金調達、ヘルスケアインフラの拡大の組み合わせによってもたらされます。特にマラリア原虫やマラリア原虫の薬剤耐性株が出現しているため、マラリア流行地域ではマラリアの発生率が高く、効果的で利用しやすい治療に対する強い需要が生まれ続けています。国際保健機関、政府、製薬企業による投資の増加により、新しい治療法や診断法の研究開発が加速しています。低・中所得国におけるヘルスケアサービスへのアクセス拡大により、ACTや関連薬剤の早期発見とより広範な投与が可能になりつつあります。バイオテクノロジーと分子生物学の技術的進歩により、有効性が向上し、耐性の可能性が低い次世代抗マラリア薬の開発が可能になりつつあります。政府の政策改革や医療保険への取り組みにより、特にサハラ以南のアフリカや東南アジアの一部では、十分な治療を受けていない人々の治療に対する障壁が低くなっています。公衆衛生教育やアドボカシー・キャンペーンを通じた意識の向上により、医療を求める行動や治療レジメンのアドヒアランスが改善されつつあります。母子保健サービスへのマラリアプログラムの統合は、最も脆弱なライフステージにおける症例発見と介入を後押ししています。現地の保健機関、非政府組織、国際的なパートナー間の協力関係の強化も、より良い配布、モニタリング、フォローアップケアの確保につながっています。こうした複合的な要因がマラリア治療市場の力強い成長を促し、人命救助だけでなく、マラリア感染地域における長期的な市場開拓と社会的公平性を推進する上でも、世界の保健衛生の優先事項としての重要性を高めています。

セグメント

治療（ジェネリック医薬品治療、先発医薬品治療、ワクチン治療）;流通チャネル（病院薬局、小売薬局、オンライン流通チャネル）;投与経路（経口投与、非経口投与）

調査対象企業の例

• Ajanta Pharma Ltd.
• Bayer AG
• BioNTech SE
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• F. Hoffmann-La Roche AG
• Ginkgo Bioworks（via malaria pipeline）
• GlaxoSmithKline plc（GSK）
• Guilin Pharmaceutical Co., Ltd.
• Ipca Laboratories Ltd.
• Lyndra Therapeutics
• Lupin Limited
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• Sanaria Inc.
• Sanofi
• Strides Pharma Science Ltd.
• Torrent Pharmaceuticals Ltd.
• Zydus Cadila

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Malaria Treatment Market to Reach US$22.4 Billion by 2030

The global market for Malaria Treatment estimated at US$5.3 Billion in the year 2024, is expected to reach US$22.4 Billion by 2030, growing at a CAGR of 27.2% over the analysis period 2024-2030. Generic Drug Treatment, one of the segments analyzed in the report, is expected to record a 26.3% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the Originators Treatment segment is estimated at 29.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 35.6% CAGR

The Malaria Treatment market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.5 Billion by the year 2030 trailing a CAGR of 35.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 22.1% and 24.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 22.9% CAGR.

Global Malaria Treatment Market - Key Trends & Drivers Summarized

Why Does Malaria Treatment Continue to Be a Public Health Priority Across Endemic Regions?

Malaria treatment remains a major focus of global public health efforts due to the disease’s widespread impact, particularly in tropical and subtropical regions where it causes hundreds of thousands of deaths annually, with children under five being the most vulnerable group. Despite significant progress in prevention and awareness, malaria continues to challenge health systems in Africa, Southeast Asia, parts of Latin America, and Oceania. The complexity of the disease, which is transmitted by the Anopheles mosquito and caused by Plasmodium parasites, requires targeted treatment protocols that vary depending on the species involved and the drug resistance patterns in the region. In most cases, Plasmodium falciparum poses the highest risk due to its rapid replication and potential to cause severe complications if not treated promptly. Prompt diagnosis followed by effective drug administration is critical to reducing the disease’s burden and preventing its spread. National and international health agencies prioritize malaria treatment in their strategies due to its association with poverty, reduced workforce productivity, and high rates of morbidity and mortality. The World Health Organization continues to support countries in deploying artemisinin-based combination therapies (ACTs), which have become the gold standard for treating uncomplicated malaria. However, the emergence of drug resistance in parts of Asia and Africa has underscored the need for continuous monitoring and research. Efforts to increase access to diagnostics, medications, and community health interventions make malaria treatment not just a medical issue but a developmental one that influences economic growth and quality of life in affected regions.

How Are Advancements in Drug Development and Diagnostics Enhancing Malaria Management?

Innovations in pharmaceutical research and diagnostics are transforming the way malaria is diagnosed, treated, and managed, bringing new hope to efforts aimed at controlling and eventually eliminating the disease. Artemisinin-based combination therapies remain the frontline treatment, but new formulations and second-generation antimalarial compounds are being developed to address the growing concern of resistance. Researchers are focusing on creating single-dose treatments, fixed-dose combinations, and long-acting therapies that simplify treatment protocols and improve adherence, especially in rural or resource-limited settings. Meanwhile, point-of-care diagnostics such as rapid diagnostic tests (RDTs) have significantly improved early detection, allowing healthcare workers to distinguish between different Plasmodium species without the need for sophisticated lab infrastructure. These tools are critical in guiding appropriate treatment decisions and avoiding the misuse of antimalarial drugs, which can accelerate resistance. Additionally, advances in genomic studies are helping scientists understand the evolution of parasite resistance and develop targeted therapies that remain effective over time. Injectable antimalarial drugs and new intravenous formulations are being introduced for severe cases, allowing for faster patient stabilization and reduced mortality in emergency settings. Several pipeline drugs, including novel endoperoxide compounds and transmission-blocking agents, are under clinical trials, aimed at expanding the therapeutic arsenal. Digital health tools and mobile platforms are being used to track outbreaks, monitor treatment efficacy, and ensure medication delivery in hard-to-reach communities. These advancements are not only enhancing patient outcomes but also strengthening public health systems by providing more accurate data and tools for intervention.

What Global Health and Socioeconomic Trends Are Influencing Malaria Treatment Strategies?

Global health priorities and socioeconomic dynamics are playing a pivotal role in shaping malaria treatment strategies and determining how effectively health systems can respond to outbreaks. Climate change, urbanization, and changes in land use are affecting mosquito habitats, leading to shifts in malaria transmission patterns and expanding the range of the disease into previously unaffected areas. Migration and refugee movements are also contributing to the spread of malaria, often straining local health infrastructure in receiving regions. Economic inequality continues to limit access to timely diagnosis and treatment for marginalized populations, making malaria both a cause and consequence of poverty. Health ministries and international donors are increasingly focused on integrating malaria treatment into broader primary healthcare services, especially in rural areas where the disease burden is highest. Collaborative efforts involving public-private partnerships are enabling improved drug procurement, local manufacturing, and supply chain reliability, which are essential for sustained availability of effective treatments. Community health workers and grassroots health programs are being trained to administer first-line treatments and perform diagnostic testing, expanding the reach of national malaria programs. Education campaigns, particularly those targeting parents and caregivers, are emphasizing the importance of completing treatment regimens to avoid relapse and resistance. At the policy level, governments are working alongside organizations like the Global Fund and WHO to implement region-specific treatment protocols, support research initiatives, and facilitate international cooperation. These socioeconomic and geopolitical considerations highlight the complexity of malaria treatment and the need for multifaceted strategies that extend beyond pharmaceuticals to include infrastructure, education, and equity-focused policies.

What Factors Are Driving Growth in the Global Malaria Treatment Market?

The growth in the global malaria treatment market is driven by a combination of epidemiological urgency, scientific innovation, international funding, and expanding healthcare infrastructure. The high incidence of malaria in endemic regions continues to create strong demand for effective and accessible treatments, especially as drug-resistant strains of Plasmodium falciparum and Plasmodium vivax emerge. Increased investment by global health organizations, governments, and pharmaceutical companies is accelerating research and development of new therapies and diagnostics. Expanding access to healthcare services in low- and middle-income countries is enabling earlier detection and more widespread administration of ACTs and related medications. Technological advances in biotechnology and molecular biology are allowing for the development of next-generation antimalarial drugs with improved efficacy and lower resistance potential. Government policy reforms and health insurance initiatives are reducing barriers to treatment in underserved populations, particularly in Sub-Saharan Africa and parts of Southeast Asia. Greater awareness through public health education and advocacy campaigns is improving health-seeking behavior and adherence to treatment regimens. The integration of malaria programs into maternal and child health services is boosting case detection and intervention during the most vulnerable life stages. Increasing collaboration between local health agencies, non-governmental organizations, and international partners is also ensuring better distribution, monitoring, and follow-up care. These collective factors are driving robust growth in the malaria treatment market and reinforcing its importance as a global health priority, not only for saving lives but also for advancing long-term development and social equity in malaria-affected regions.

SCOPE OF STUDY:

The report analyzes the Malaria Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Generic Drug Treatment, Originators Treatment, Vaccines Treatment); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel); Administration Route (Oral Administration, Parenteral Administration)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Ajanta Pharma Ltd.
• Bayer AG
• BioNTech SE
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• F. Hoffmann-La Roche AG
• Ginkgo Bioworks (via malaria pipeline)
• GlaxoSmithKline plc (GSK)
• Guilin Pharmaceutical Co., Ltd.
• Ipca Laboratories Ltd.
• Lyndra Therapeutics
• Lupin Limited
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• Sanaria Inc.
• Sanofi
• Strides Pharma Science Ltd.
• Torrent Pharmaceuticals Ltd.
• Zydus Cadila

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Malaria Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Malaria Burden in Endemic Regions Throws the Spotlight on Treatment Innovation as a Global Health Imperative
  • Increasing Focus on Elimination and Control Campaigns Propels Demand for Scalable, Fast-Acting Antimalarial Therapies
  • Here's the Story: Emergence of Drug-Resistant Plasmodium Strains Strengthens the Business Case for Next-Generation Combination Therapies
  • Expansion of Artemisinin-Based Combination Therapy (ACT) Remains the Gold Standard but Faces Pressure from Evolving Resistance Patterns
  • Improved Access to Rapid Diagnostic Tests (RDTs) Supports Timely and Targeted Malaria Treatment Deployment
  • Growth in Pediatric and Pregnancy-Safe Formulations Fuels Inclusion of Vulnerable Populations in Malaria Control Strategies
  • Here's How Mass Drug Administration (MDA) Programs Are Driving Preventive and Community-Based Treatment Demand
  • Global Health Funding from Entities Like WHO, Global Fund, and USAID Sustains Market for Affordable Malaria Treatments
  • Rise in Traveler and Imported Malaria Cases in Non-Endemic Regions Spurs Demand for Prophylaxis and Emergency Treatment
  • Here's How mRNA and Gene-Based Therapeutics Are Emerging as Future Tools Against Drug-Resistant Malaria
  • Integration of Mobile Health Platforms and Supply Chain Tools Enhances Treatment Delivery and Remote Monitoring
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Malaria Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Malaria Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Generic Drug Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Generic Drug Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Generic Drug Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Originators Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Originators Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Originators Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Vaccines Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Vaccines Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Vaccines Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• JAPAN
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• CHINA
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• EUROPE
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Malaria Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• FRANCE
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• GERMANY
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Malaria Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• INDIA
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Malaria Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Malaria Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• AFRICA
  • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030

IV. COMPETITION